INTRODUCTION
To maintain the adult hematopoietic system, an ongoing and flexible interplay between lineage-instructive transcription factors and epigenetic regulators is likely to play a central role in determining appropriate numbers of each cell type. Several sequence-specific transcriptional regulators have been shown to play important roles in hematopoiesis, but the role of chromatin-modifying epigenetic regulators in this process is less clear. Polycomb (PcG) and trithorax (trxG) family proteins first identified in Drosophila melanogaster influence target gene expression in a manner that is heritable through multiple daughter cell divisions (Cavalli and Paro, 1998; Cavalli and Paro, 1999) , making these proteins uniquely qualified to influence cell identity and plasticity during development or to regenerate tissues such as the hematopoietic system.
The Mixed Lineage Leukemia (MLL) gene was the first trxG gene identified as a proto-oncogene (Djabali et al., 1993; Domer et al., 1993; Gu et al., 1992; Tkachuk et al., 1992) . Chromosomal translocations disrupting the MLL gene are primarily associated with acute lymphocytic (ALL) or myelogenous leukemia (AML) of infants, as well as secondary AML, accounting for more than 70% of each these two groups (reviewed in Biondi et al., 2000; Pui and Relling, 2000) . MLL fusion genes produced by chromosomal translocation encode proteins composed of the Nterminal $1/3 of MLL fused to one of over 50 identified translocation partners. The expression of MLL fusion proteins can influence lineage fidelity within the hematopoietic system (Drynan et al., 2005) and can produce cells with mixed lineage identity in human leukemia (Armstrong et al., 2002) .
Retroviral expression of MLL fusion proteins in bone marrow cells is sufficient to produce AML or ALL in the mouse, as is the expression of MLL fusions by knockin or cre-mediated de novo chromosomal translocation (Ayton and Cleary, 2001; Daser and Rabbitts, 2005) . The retroviral transduction model enabled structure-function assays that identified motifs within the MLL N terminus and the fusion partner that are essential for transformation. Collectively, such experiments indicate that MLL fusion proteins act via a gain-of-function mechanism through the acquisition of ectopic transactivation or dimerization capacity (reviewed in Ayton and Cleary, 2001) . The N-terminal portion of MLL is likely to play a large role in targeting the fusion proteins to many of the same loci regulated by endogenous MLL, as fusion proteins have been shown by chromatin immunoprecipitation (ChIP) to localize to at least some of the same regulatory sequences as full-length wild-type MLL Xia et al., 2005) and increase expression of those target genes (Horton et al., 2005) .
Recent advances in purifying native MLL and complexes from cell lines have yielded important insights into the mechanism by which MLL acts on its target genes. Such complexes harbor histone methylation, acetylation, and chromatin remodeling activities (Milne et al., 2002; Nakamura et al., 2002; Wysocka et al., 2005; Yokoyama et al., 2004) . The Su(var)3-9/Enhancer of zeste/Trithorax (SET) domain at the extreme C terminus of MLL methylates histone H3 at lysine 4 (H3 K4), a modification associated with active transcription (Santos-Rosa et al., 2002) . Consistent components of these complexes include WDR5, ASH2L, and menin. WDR5 and ASH2L interact with the C-terminal SET domain, acting as cofactors for the histone methyltransferase activity (Dou et al., 2006; Steward et al., 2006) . Menin interacts with the MLL N terminus and bridges MLL to the basal transcriptional machinery (Yokoyama et al., 2004) . The interaction of menin with the N terminus of MLL is important for maintaining expression of an endogenous MLL target gene in HeLa cells and is essential for transformation by MLL fusion proteins (Yokoyama et al., 2004 (Yokoyama et al., , 2005 . Other proteins have been described as part of the MLL complex, or as transient interactors, but scant in vivo data are available to validate the biological importance of these interactions.
To understand the mechanisms by which MLL fusion proteins are leukemogenic, it is critical to determine the normal function of MLL in vivo, particularly in the cell types that may represent the target for transformation by MLL oncogenes. Several groups have disrupted the Mll gene by different strategies, and in most cases, homozygous Mll mutants die during embryogenesis Yagi et al., 1998; Yu et al., 1995) . Interestingly, the deletion of the SET domain alone is not lethal, but homozygous mutants exhibit mild loss-of-function phenotypes, including homeotic transformation and reduced expression of several Hox genes (Terranova et al., 2006) .
Due to the embryonic lethality of most Mll mutants, studies aimed at identifying the role of Mll in the hematopoietic system have focused on embryonic hematopoiesis. Experiments using Mll-deficient embryonic stem (ES) cells demonstrated that these cells were incapable of differentiating into any hematopoietic cell types in adult animals or in the fetal liver. This multilineage block was due to the lack of HSCs in Mll-deficient embryos as measured functionally (Ernst et al., 2004a) . Using an in vitro system, we showed that the block in hematopoietic development was accompanied by global reduction in Hox gene expression and could be rescued by the reintroduction of individual Hox genes (Ernst et al., 2004b) . These experiments indicate that Mll plays an essential role in the development of definitive HSCs during embryogenesis and suggest that this is due to global Hox gene misexpression. However, the early and severe nature of the block in hematopoietic development precluded a detailed analysis of the mechanisms underlying the lack of HSCs or the assessment of Mll function in more differentiated hematopoietic lineages. To address these questions, we developed a mouse model in which Mll can be inducibly inactivated in the bone marrow and in specific lineages to provide a model system in which such functions could be studied in more detail.
RESULTS

Excision of Mll Exons 3 and 4 Generates a Loss-of-Function Allele
To create an inducible loss-of-function model for Mll, we designed an in-frame deletion to remove the AT hooks, nuclear targeting sequences (NTS), and subnuclear localization (SNL) sequences by flanking exons 3 and 4 with loxP sites (''floxed,'' Mll F ). Thus, cre recombinase-mediated excision produces an intragenic deletion (Mll DN ), resulting in an MLL mutant protein lacking several NTS and other interaction motifs ( Figure 1A ). We recently introduced this allele into ES cells in combination with a strong loss-of-function allele (Mll-lacZ) and found that these cells exhibited a block in hematopoietic development (Ernst et al., 2004a ) and a block in embryoid body hematopoiesis (Ernst et al., 2004b) . Embryos homozygous for the Mll DN allele died in utero at embryonic day 12.5, one day later in embryo development than Mll DN /Mll-lacZ and two days later than Mll-lacZ homozygotes ( Figure S1 in the Supplemental Data available with this article online). Mll DN/+ animals exhibit normal viability and fertility and can be backcrossed to the C57Bl/6 strain without loss of heterozygote viability, in contrast to the exon 3 insertion Mll-lacZ strain (Yu et al., 1995) . Thus, both the age of embryonic lethality and the hematopoietic phenotypes indicate that the Mll DN allele is a strong hypomorphic allele of Mll, slightly less severe than the Mll-lacZ allele.
To confirm the predicted subcellular distribution of the MLL DN protein, we expressed an N-and C-terminally tagged version of the predicted protein encoded by Mll DN in 293T cells. MLL is processed by proteolytic cleavage to produce N-and C-terminal polypeptides that associate with each other within a large protein complex (Hsieh et al., 2003; Yokoyama et al., 2002) . To determine the localization of both protein fragments, cells transfected with tagged wild-type and MLL DN constructs were visualized by fluorescence microscopy using antibodies to the N-and C-terminal tags, as well as an internal MLL antibody that recognizes an epitope in the N-terminal fragment. MLL DN was clearly excluded from the nucleus as determined by the N-terminal anti-Flag or anti-MLL antibodies, as well as the C-terminal anti-HA antibody ( Figure 1B ). In contrast, the full-length protein was exclusively nuclear as expected ( Figures 1B and 1C ). This subcellular localization was also observed with antibodies that detect the endogenous MLL DN protein produced by cre-mediated Mll excision in Mll F/F bone marrow-derived macrophages ( Figure 1C ). Western blot analysis demonstrated similar levels of the MLL DN protein compared to wild-type (data not shown).
To independently assess the function of the MLL DN protein, we examined the expression of Hoxa7, Hoxa9, and Hoxa10, well-characterized MLL target genes, in Mll DN/DN hematopoietic cells. As shown in Figure 1D , we observed a progressive reduction (2-to $50-fold) in Hoxa7, Hoxa9, and Hoxa10 expression between days 6 and 11 after cre-mediated excision of Mll. Other Hox genes, such as Hoxb3, were not affected by Mll loss Kuhn et al., 1995) . Control and Mx1-cre;Mll F/F animals were subjected to a brief series of polyinosinic:polycytidylic acid (pI:pC) injections to induce cre-mediated excision of Mll in the bone marrow. Prior to pI:pC injection, bone marrow populations did not differ between control and Mx1-cre;Mll F/F animals ( Figure S4 ). As early as 4 days after the first pI:pC injection, nearly all bone marrow cells had undergone cre-mediated excision ( Figure S5 ). Approximately 19 days after inducing cre expression, animals in which 80% or more of the bone marrow expressed the Mll DN allele exhibited bone marrow cytopenia and died or had to be sacrificed (Figure 2 Cell Stem Cell cre-mediated Mll deletion until the point at which Mx1-cre;Mll F/F animals died. Notably, the number of KSL cells dropped precipitously and failed to recover ( Figure 3A ). To determine whether the reduction in KSL cells reflected a cell-intrinsic defect, we performed competitive transplantation experiments with sorted pooled cells from the day 8 time point. We injected up to 10,000 viable KSL cells purified by fluorescence-activated cell sorting (FACS) from pI:pC-treated Mx1-cre;Mll F/F or control animals into lethally irradiated recipients. Animals injected with wildtype KSL cells all exhibited donor-derived cells in the peripheral blood; however, Mll DN/DN KSL cells failed to yield any significant donor contribution as early as 3 weeks after transplantation ( Figure 3A , inset) or as late as 20 weeks (data not shown).
To determine whether HSC activity was present independent of the cell-surface phenotype, unfractionated Mll DN/DN bone marrow cells were tested in competitive transplantation experiments. We tested either equal numbers (1:1) or a 10-fold excess (10:1) of Mll DN/DN bone marrow mixed with wild-type bone marrow cells (Figures 3B and 3C) . Remarkably, even a 10-fold excess of Mll DN/DN cells yielded recipients that were engrafted exclusively by wild-type cells ( Figure 3C ). Thus, Mll deletion results in the rapid decline in a phenotypically-defined HSC-enriched population and loss of HSC activity from this population and, in fact, from the bone marrow in general.
Consequences of Mll Deletion on HSC Viability and Proliferation
One explanation for the inability of Mll DN/DN KSL to compete with wild-type cells in transplantation experiments, as well as their disappearance from conditional knockout bone marrow, is that cells undergo programmed cell death in response to Mll deletion. In fact, an Mx1-creinduced knockout of the antiapoptotic Mcl-1 gene exhibits very similar kinetics of bone marrow cytopenia and HSC loss (Opferman et al., 2005) . To determine whether cell death occurs in response to Mll loss, we assessed Annexin V and propidium iodide (PI) staining of KSL cells throughout the time course after Mll deletion. As shown in Figure 4A , we found no significant difference in the proportion of Annexin V + KSL cells at any time point. Annexin V + cells were detectable in other populations in the bone marrow, but there were no significant differences between the two genotypes in any population tested, nor was there a difference in the overall viability (PI + ) at early time points (day 0-11, data not shown).
Because programmed cell death did not account for the engraftment and homeostasis defects identified in Mlldeficient KSL cells, we considered growth arrest as an alternative hypothesis. For these experiments, we assessed the proportion of KSL cells in cycle by using 12 hr bromodeoxyuridine (BrdU) pulses (Figures 4B and 4C) . Cell-surface staining was performed to identify KSL cells followed by intracellular staining for BrdU detection Figures 4C and 4D ). We (Kiel et al., 2005) . Four days after cre induction (prior to the increase in S phase cells), we found that Mll DN/DN CD48 neg /KSL cells consistently exhibited a shift from G 0 to G 1 relative to control cells ( Figures 4E and 4F ). Therefore the first defect observed in Mll DN/DN HSCs is the failure to maintain quiescence, followed shortly thereafter by an increased number of cycling KSL cells. These data suggest that the depletion of HSCs upon Mll loss is due to their failure to self-renew and maintain a noncycling population of HSCs.
To determine whether Mll DN/DN HSCs and their progeny are ultimately depleted in vivo due to a failure to selfrenew, we generated chimeric animals in which cotransplanted wild-type bone marrow supports long-term animal viability. Bone marrow chimeras were generated with Ly5. Figures  5C-5E ). Because whole bone marrow was transferred, the fact that peripheral blood T-and B cells were not completely depleted ( Figures 5C and 5D ) likely reflects the long half-life of these cells (>12 weeks; Forster and Rajewsky, 1990; Kondo et al., 1997) , whereas the more rapid and complete loss of Mll DN/DN neutrophils (half-life of 1 to 2 days) reflects the complete exhaustion of Mll
DN/DN
HSCs. These data demonstrate that Mll-deficient HSCs are completely depleted, even in a bone marrow environment that includes wild-type neighboring hematopoietic cells and does not become cytopenic. However, these data do not account for the rapid cell loss in pI:pC-injected Mx1-cre;Mll F/F animals ( Figure 2A ). To investigate this further, we focused on the consequences of Mll deletion on progenitor populations.
Mll Plays an Independent Role in Maintaining Progenitor Pools
To determine whether lineage-committed progenitors were also affected by the loss of MLL function, we analyzed representative myeloid and lymphoid progenitor populations by cell-surface phenotype. We found that the absolute number of common lymphocyte progenitors (CLP), common myeloid progenitors (CMP), granulocytemacrophage progenitors (GMP), and megakaryocyteerythrocyte progenitors (MEP) was reduced 1.4-to 4-fold by day 11 after Mll deletion ( Figure 6A ). This was predominantly due to an overall reduction in lin neg/low / c-Kit + cells (3.8-fold, data not shown).
To examine progenitor frequencies prior to their phenotypic reduction, we subjected bone marrow from the day 6 time point to in vivo (colony-forming units-spleen day 8 [CFU-S 8 ]) and in vitro (colony-forming unit-culture [CFU-C]) clonal progenitor assays. Reduced myeloid, erythroid, and lymphoid colony frequencies were observed with Mll DN/DN bone marrow samples (2-to 5-fold, Figures  6B-6F) . The reduction in all colony types suggests a uniform requirement for Mll in the primitive hematopoietic compartment.
The maintenance of progenitors in vivo may reflect an intrinsic requirement for Mll within the progenitor pool or (F) CFU-C assay using bone marrow cells prepared as in (E) but anti-IL7Ra and -Sca-1 were included in the lineage mix. Cells from at least three donors per genotype were plated in triplicate, and colonies were scored 7 days later. Represented are the averages from all replicates with error bars indicating the 95% confidence interval of the averages. Megakaryocyte/erythroid, Meg/E; burst formation unit-erythroid, BFU-E; granulocyte, G; macrophage, M; granulocyte/macrophage, GM; and granulocyte, erythroid, macrophage, megakaryocyte colony, GEMM.
(G) CFU-C assay using in vitro- induction. Samples were cultured in liquid medium containing SCF, IL-3, and IL-6. Cells were pulsed for 1 hr with BrdU, harvested, and analyzed by flow cytometry at the indicated time points, reflecting days of in vitro culture. Error bars represent 95% confidence intervals.
(I) Cells as described above were incubated with low serum and cytokine-free medium overnight, followed by readdition of serum and cytokines for 1 hr followed by BrdU pulses as in (H). Error bars represent 95% confidence intervals. , respectively). Also tested are the populations predicted to be affected in the lineage-specific cre strains:
332 Figure 6G ). Together, these data indicate that Mll is required for the maintenance of myelo-erythroid progenitors through a cellintrinsic mechanism.
Proliferation Defects in Mll
DN/DN
Myelo-Erythroid Progenitors
To determine the basis for the functional and phenotypic reduction in Mll DN/DN progenitors, we assessed cell death and proliferation. We found no significant difference between the viability of Mll DN/DN cells in vivo or using the in vitro cre excision strategy described above (data not shown). We assessed proliferation in vitro by using a pool of myelo-erythroid progenitors (lin neg/low /IL7Ra
À cells encompassing the CMP, GMP, and MEP populations). Using a time course of in vitro BrdU pulses, we found that Mll DN/DN progenitors exhibited reduced proliferation relative to controls ( Figure 6H ). In addition, serum/cytokine starvation experiments demonstrated that Mll DN/DN progenitors exhibited a 2.6-fold reduction in cells that could re-enter the cell cycle upon serum and cytokine restoration ( Figure 6I) . Importantly, the composition of the cell populations before or after in vitro culture was not significantly different between wild-type and Mll DN/DN populations ( Figure S7 and data not shown). Based on these results, we conclude that Mll is required to sustain cytokine-driven proliferation of myelo-erythroid progenitors. Thus, the combination of ectopic, nonrenewing HSC proliferation in conjunction with the reduced proliferation within the larger progenitor pool (lin neg/low /c-Kit + )
is likely to play a major role in the rapid attrition of cells in the pI:pC-injected Mx1-cre;Mll F/F animals. (Figures 3 and 5) was not due to a late block in T cell, B cell, or granulocyte differentiation, and therefore accurately reflect a defect in stem/progenitor function.
Differentiating T-, B-, and Myeloid Cells No Longer
Due to the contrast of these results with the severe, multilineage phenotype observed in early progenitors, we considered compensation by Mll homologs as an explanation for the differential effect of Mll deletion on primitive versus more mature, lineage-committed cell types. The Mll homologs Mll-2 through -4 exhibit similar domain organization and encode SET domains predicted to methylate histone substrates with the same specificity (FitzGerald and Diaz, 1999; Prasad et al., 1997; Ruault et al., 2002) . Mll-2, the most closely related homolog, is expressed in a similar manner to Mll in the hematopoietic system (see below). MLL-2 has been isolated in similar protein complexes as MLL and has also been localized to the same target gene by ChIP Hughes et al., 2004; Nakamura et al., 2002; Yokoyama et al., 2004 Figure S8 ). The overlap in expression of Mll homologs illustrates the potential for compensatory functions within in these cell types; however, Mll-2 and -3 are also expressed significantly within the KSL population and thus would be equally capable to compensate for Mll-1 loss in stem and progenitor populations, which is not the case. These data demonstrate that the selective expression of Mll homologs within the hematopoietic system cannot account for the selective effects of Mll-1 loss shown in this study. Despite the expression of Mll-2 and -3 within stem and progenitor populations, Mll-1 performs an essential and nonredundant role in maintaining HSCs and progenitors ( Figure 7H ). In the more mature populations, it is possible that the relatively high levels of Mll-2, -3, and -4 compensate for Mll-1 loss, but a definitive test of this hypothesis will require the analysis of compound mutants.
DISCUSSION
The central finding of this study is that adult steady-state hematopoiesis depends on Mll, based on essential Cell Stem Cell functions performed within hematopoietic stem and progenitor cells. In the absence of Mll, HSCs exit from a quiescent state and precociously undergo cell-cycle entry. Ectopic cycling of HSCs occurs without an increase in this population and coincident with functional deficits, suggesting that cell division in this compartment is accompanied by differentiation and not self-renewal. In contrast, the role of Mll within primitive myelo-erythroid progenitors appears to be quite distinct, in that progenitor frequency is reduced upon Mll deletion through a mechanism involving reduced proliferation. In conjunction with germline lossof-function analyses (Ernst et al., 2004a) , the studies presented here demonstrate that Mll is necessary for both the development and maintenance of HSCs. Further characterization will reveal whether all of these MLL-dependent processes utilize common or distinct molecular pathways. Our data generally support the concept that MLL acts on a selective set of target genes in different cell types. Based on a genome-wide ChIP study in the U937 cell line, it has been proposed that MLL functions as a transcription start site-specific global transcriptional regulator (Guenther et al., 2005) . This conclusion is partly based on the large overlap in Pol II and MLL localization at active promoters. If this colocalization indicated a biologically important association, one would expect a severe consequence for all cells in which MLL activity is removed. This prediction is difficult to reconcile with the selective phenotypes observed in vivo upon Mll loss. For example, ES cells and many differentiating tissues in chimeric animals are unaffected by Mll deficiency (Ernst et al., 2004a; Ernst et al., 2004b) . These observations, along with the results presented in this study, suggest that selective and distinct target genes are regulated by MLL and its homologs in different tissues.
The reduced proliferation of myelo-erythroid progenitors shown in this study is consistent with previous observations using embryoid body-derived hematopoietic progenitors. In these studies, the reduced expression of multiple Hox genes appeared to be the primary cause for the reduced colony frequency in Mll mutant embryoid bodies (Ernst et al., 2004b) . Thus, we predict that the reduced Hox gene expression in progenitors is similarly likely to play a major role in reduced progenitor frequency and proliferation upon Mll deletion. Conversely, Hoxa7 and Hoxa9 are consistently overexpressed in MLL fusion-initiated leukemia in humans and in mouse models, and are rate limiting for leukemogenesis or influential in determining leukemic cell phenotype (Armstrong et al., 2002; Ayton and Cleary, 2003; Kumar et al., 2004; So et al., 2004) . Based on the results of the current study and results of Hox expression analyses in Mll loss-and gain-of-function experiments (Ernst et al., 2004b; Horton et al., 2005) , we propose that altered Hox gene expression may be responsible for the proliferation component of the leukemogenic program induced by MLL fusion proteins.
The regulation of quiescence in HSCs is less likely to be explained by Hox gene maintenance alone, based on analyses of individual and compound Hox gene knockouts in which such a phenotype has not been reported (Bijl et al., 2006; Brun et al., 2004; Lawrence et al., 2005) . This suggests that there are other HSC-specific Mll target genes involved in this process. Such HSC-specific target genes may remain activated by MLL fusion oncoproteins as HSCs differentiate, resulting in the maintenance of a self-renewal program coincident with a proliferationpromoting program mediated by Hox gene overexpression. Candidate genes for this self-renewal program include those reported as reactivated in an MLL-AF9 leukemia model (Krivtsov et al., 2006) . Leukemia can be initiated by introducing MLL fusion oncogenes into committed progenitors (Cozzio et al., 2003; Krivtsov et al., 2006; Somervaille and Cleary, 2006) , suggesting that the reactivation of such a self-renewal program by MLL fusion oncogenes can occur in progenitors. However, the introduction of MLL fusion oncogenes into HSCs rather than progenitors may facilitate fusion protein access to a quiescence-promoting gene expression program. One prediction of this hypothesis is that the introduction of Mll fusions into HSCs (rather than progenitors) would result in a more persistent, chemotherapy-resistant pool of leukemic cells, a concept that has not been tested in mouse models.
Importantly, our studies suggest that targeting MLL fusion oncogenes through mechanisms that generally interfere with MLL function may cause bone marrow failure. Thus it will be essential to identify strategies that selectively target MLL fusion oncoproteins without compromising wild-type MLL function. This effort will be aided by a comprehensive assessment of target genes affected by MLL fusions versus those affected by wild-type MLL.
EXPERIMENTAL PROCEDURES
Mice, Competitive Transplantation, and CFU-S Assays Animals were maintained in accord with the Dartmouth Animal Resources Center and I.A.C.U.C. policies. Mll floxed alleles and ES targeting have been described (Ernst et al., 2004a -gln] , 100 U/ml penicillin G, 100 mg/ml streptomycin [P/ S], and 50 mM 2-ME) supplemented with 40 ng/ml IL-6, 20 ng/ml IL-3, 40 U/ml LIF, 80 ng/ml SCF, and 10 mg/ml polybrene. Spin infection was performed for 30 min at 25 C in 96-well plates. FACS-purified GFP + cells were subjected to colony assays as described (Ernst et al., 2004b) . For the proliferation assays, lin neg/low cells were enriched as described above from Mx1-cre;Mll F/F or Mll F/F animals at day 11 post cre induction. Cell densities were adjusted to 5 3 10 5 cells/mL in growth medium supplemented with 1XBIT (StemCell Technologies), 50 ng/mL SCF, 10 ng/mL IL-3, and 10 ng/mL IL-6. Cells were incubated with BrdU at 10 mM for 1 hr. For the starvation experiment, cells were grown for 2 days, washed and incubated in cytokine-free, 0.5% FBS growth medium overnight, shifted to complete medium, and then pulsed with BrdU as described above. For the pre-B colony assay, 10,000 lin neg/low cells were plated in Methocult M3630 (StemCell Technologies) supplemented with 100 ng/mL SCF, 20 ng/mL murine Flt3L, and 10 ng/mL IL-7. Pre-B colonies were scored after 7 days. Cytokines were from R&D Systems.
Real-Time, Quantitative PCR Total RNA from the sorted populations indicated in Figure 7 was purified with the RNeasy Mini kit (QIAGEN). After extraction, 1 mg MS2 bacteriophage RNA (Roche) was added as a carrier, and mRNA was amplified with the RiboAmp RNA Amplification Kit (Arcturus) per the manufacturer's recommendations for one round of amplification. Hox gene detection was performed as described (Ernst et al., 2004b) , and Mll family primer and probes are shown in Figure S5 . Relative expression levels were determined by using the DDCt method (Livak and Schmittgen, 2001 ) with data from triplicate multiplexed reactions normalized to Gapdh. Quantitative real-time PCR was performed on a 7900HT machine using the 9600 emulation setting (Applied Biosystems). Cell Culture, Transfection, and Immunofluorescence 293T cells were maintained in DMEM supplemented with 10% FBS, 200 mM L-gln, P/S, and 100 nM NEAA and transfected with FuGENE 6 (Roche). Thirty-six hours posttransfection, cells were plated on coverslips and grown overnight before fixing in 4% paraformaldehyde in PBS for 5 min. Cells were then blocked with PBS containing 2% goat serum and 0.2% Triton X-100 overnight. Anti-Flag M2 (1:100, Sigma), anti-MLL1 (BL1290), and anti-HA (both 1:100, Bethyl Labs) were incubated with coverslips for 30 min at room temperature, then washed three times in PBS. Detection was performed with Alexa Fluor-568 goat anti-mouse or Alexa Fluor-488 goat anti-rabbit (both at 1:1000, Molecular Probes). Stained cells were then washed three times in PBS, with the final wash containing 1mg/mL 4 0 , 6-diamidino-2-phenylindole (DAPI). Coverslips were mounted onto slides with Prolong Gold antifade medium (Molecular Probes). Images were captured with a Zeiss AxioVisionZ1 microscope and analyzed in Adobe Photoshop. Macrophages were cytospun onto slides and stained as described above. animals were intercrossed and embryo age was defined considering the day of plug observation (8 a.m.) as day 0.5 post-coitum (dpc). Pregnant females were sacrificed at the embryonic day indicated and viable embryos were scored based on cardiac contractions. All embryos were genotyped by Southern blot or the 3 primer assay presented in Fig. S5 using yolk-sac or limb bud genomic DNA. 
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